Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$4.61 - $116.0 $4,610 - $116,000
1,000 New
1,000 $4,000
Q1 2022

May 04, 2022

SELL
$5.28 - $9.17 $5,280 - $9,170
-1,000 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$7.21 - $10.49 $5,191 - $7,552
-720 Reduced 41.86%
1,000 $8,000
Q2 2021

Aug 02, 2021

SELL
$8.48 - $13.61 $4,240 - $6,805
-500 Reduced 22.52%
1,720 $17,000
Q1 2021

May 13, 2021

BUY
$12.96 - $19.75 $12,960 - $19,750
1,000 Added 81.97%
2,220 $31,000
Q4 2020

Feb 10, 2021

SELL
$12.74 - $18.49 $10,192 - $14,791
-800 Reduced 39.6%
1,220 $17,000
Q3 2020

Nov 12, 2020

BUY
$5.86 - $18.47 $11,837 - $37,309
2,020 New
2,020 $37,000

Others Institutions Holding TFFP

# of Institutions
1
Shares Held
1M
Call Options Held
0
Put Options Held
0

About TFF Pharmaceuticals, Inc.


  • Ticker TFFP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,477,800
  • Market Cap $8.66M
  • Description
  • TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...
More about TFFP
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.